You are here

QVA149

With a new FDA nod, Novartis enters a crowded COPD field

Fierce Biotech

Fri, 10/30/15 - 11:15 am

Novartis' duo of COPD drugs clears Phase III on the path to an FDA decision

Fierce Biotech

Fri, 05/22/15 - 10:41 am

Novartis Seeks U.S. Approval for Two COPD Drugs

Bloomberg

Thu, 01/8/15 - 08:00 am

3 Potential Game Changers for COPD

Motley Fool

Wed, 07/17/13 - 10:59 am

Boehringer Ingelheim

Novartis Smoker’s Cough Treatment Beats Glaxo’s Advair in Trial

Bloomberg Businessweek

Wed, 08/29/12 - 10:49 am

Novartis Says Smoker’s-Cough Drug Succeeded in Trials

Bloomberg

Mon, 04/2/12 - 10:43 am

Arcapta Neohaler

Seebri Breezhaler